Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

RECURSION PHARMACEUTICALS, INC.

(RXRX)
  Report
Delayed Nasdaq  -  04:00 2022-09-26 pm EDT
9.970 USD   -7.60%
09/23Beyond The Deal : Recursion's Transformational Partnership with Roche and Genentech
PU
09/19Recursion Pharmaceuticals, Inc.(NasdaqGS:RXRX) added to S&P Biotechnology Select Industry Index
CI
09/16KeyBanc Starts Recursion Pharmaceuticals at Overweight With $20 Price Target
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about RECURSION PHARMACEUTICALS, INC.
09/23Beyond The Deal : Recursion's Transformational Partnership with Roche and Genentech
PU
09/19Recursion Pharmaceuticals, Inc.(NasdaqGS:RXRX) adde..
CI
09/16KeyBanc Starts Recursion Pharmaceuticals at Overweight With $20 Price Target
MT
09/13Recursion Pharmaceuticals Starts Two New Clinical Trials of REC-4481, REC-3964
MT
09/13Recursion Initiates Two Additional Clinical Trials For a Total of Four in 2022
PR
09/13Recursion Initiates Two Additional Clinical Trials for A Total of Four in 2022
CI
09/01Recursion to Participate in Upcoming Investor Conferences
PR
08/18Insider Sell: Recursion Pharmaceuticals
MT
08/18Recursion Receives ISS ESG Prime Rating and Plans to Participate in the Goldman Sachs G..
PR
08/11Goldman Sachs Adjusts Recursion Pharmaceuticals' Price Target to $8 From $7, Keeps Neut..
MT
08/09Recursion Pharmaceuticals : Q2 Earnings Snapshot
AQ
08/09Recursion Pharmaceuticals : Provides Business Updates and Reports Second Quarter 2022 Fina..
PU
08/09Earnings Flash (RXRX) RECURSION Reports Q2 Revenue $7.7M
MT
08/09Recursion Provides Business Updates and Reports Second Quarter 2022 Financial Results
PR
08/09Recursion Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six..
CI
More most relevant news
All news about RECURSION PHARMACEUTICALS, INC.
09/23Beyond The Deal : Recursion's Transformational Partnership with Roche and Genentech
PU
09/19Recursion Pharmaceuticals, Inc.(NasdaqGS:RXRX) adde..
CI
09/16KeyBanc Starts Recursion Pharmaceuticals at Overweight With $20 Price Target
MT
09/13Recursion Pharmaceuticals Starts Two New Clinical Trials of REC-4481, REC-3964
MT
09/13Recursion Pharmaceuticals, Inc. : Other Events, Financial Statements and Exhibits (form 8-..
AQ
09/13Recursion Initiates Two Additional Clinical Trials For a Total of Four in 2022
PR
09/13Recursion Initiates Two Additional Clinical Trials for A Total of Four in 2022
CI
09/01Recursion to Participate in Upcoming Investor Conferences
PR
08/18Insider Sell: Recursion Pharmaceuticals
MT
08/18Recursion Receives ISS ESG Prime Rating and Plans to Participate in the Goldman Sachs G..
PR
More news
News in other languages on RECURSION PHARMACEUTICALS, INC.
09/13Recursion Pharmaceuticals lance deux nouveaux essais cliniques sur les produits REC-448..
09/13Recursion lance deux essais cliniques supplémentaires pour un total de quatre en 2022
08/18Vente d'initiés : Recursion Pharmaceuticals
08/09Earnings Flash (RXRX) RECURSION annonce un chiffre d'affaires de 7,7 millions de dollar..
08/09Recursion Pharmaceuticals, Inc. annonce ses résultats pour le deuxième trimestre et le ..
07/21Recursion Pharmaceuticals obtient la désignation européenne de médicament orphelin pour..
06/20Recursion annonce le lancement d'un essai de phase 2/3 pour le traitement des méningiom..
06/09Recursion Pharmaceuticals, Inc. annonce des changements de direction
05/10Earnings Flash (RXRX) RECURSION annonce un chiffre d'affaires de 5,3 millions de dollar..
05/10Recursion Pharmaceuticals, Inc. annonce ses résultats pour le premier trimestre clos le..
More news
Analyst Recommendations on RECURSION PHARMACEUTICALS, INC.
09/16KeyBanc Starts Recursion Pharmaceuticals at Overweight With $20 Price Target
MT
08/11Goldman Sachs Adjusts Recursion Pharmaceuticals' Price Target to $8 From $7, Keeps Neut..
MT
06/22Berenberg Bank Adjusts Recursion Pharmaceuticals' Price Target to $38 From $36, Maintai..
MT
05/24Goldman Sachs Lowers Recursion Pharmaceuticals' Price Target to $7 From $9, Neutral Rat..
MT
04/18BofA Securities Downgrades Recursion Pharmaceuticals to Neutral from Buy
MT
More recommendations
Press releases
09/23Beyond The Deal : Recursion's Transformational Partnership with Roche and Genentech
PU
09/13Recursion Pharmaceuticals, Inc. : Other Events, Financial Statements and Exhibits (form 8-..
AQ
09/13Recursion Initiates Two Additional Clinical Trials For a Total of Four in 2022
PR
09/01Recursion to Participate in Upcoming Investor Conferences
PR
08/18Recursion Receives ISS ESG Prime Rating and Plans to Participate in the Goldman Sachs G..
PR
More press releases
Upcoming event on RECURSION PHARMACEUTICALS, INC.